首页 › 基金 › Remedium Capital Partners, LLC › JBIO

Remedium Capital Partners, LLC 对 JBIO 的持仓历史

JADE BIOSCIENCES INC · 医疗保健

Remedium Capital Partners, LLC 在 Q3 2026 的 13F 申报中披露持有 JBIO(JADE BIOSCIENCES INC)1,807,814 股,市值约 US$25.4M,约占其申报组合的 9.28%,在其申报持仓中市值排名第 4 位。 Remedium Capital Partners, LLC 最近 4 个申报季度中有 4 个季度披露了 JBIO 持仓,最早可追溯至 Q4 2025。

最新持仓 (Q3 2026)1.81M 股
申报持仓市值$25.40M
组合权重9.28%
首次申报Q4 2025
最近变动增持
更新于2026-11-13

最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR

Remedium Capital Partners, LLC 对 JBIO 的持仓演变

Remedium Capital Partners, LLC 于 Q4 2025 首次披露 JBIO 持仓:1,577,750 股(约 US$24.3M)。 该持仓在 Q2 2026 达到峰值 1,577,750 股,市值约 US$35.1M。 在 4 次申报中,Remedium Capital Partners, LLC 1 次增持、0 次减持、2 次保持不变。 最近一期申报(Q3 2026)显示持股 1,807,814 股、市值约 US$25.4M,环比增持 230,064 股。。

逐季持仓明细

季度股数金额变化
Q4 2025 1.58M $24.34M 新进
Q1 2026 1.58M $22.17M 持有
Q2 2026 1.58M $35.06M 持有
Q3 2026 1.81M $25.40M 增持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 JBIO 与 13F 数据

JBIO(JADE BIOSCIENCES INC)属于医疗保健行业。我们追踪的基金中还有 97 只申报持有 JBIO,申报仓位最大的包括:Fairmount Funds Management LLC (US$101.2M), RA CAPITAL MANAGEMENT, L.P. (US$81.6M), Venrock Adviser, LLC (US$71.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 JBIO 的基金

查看 JBIO 的全部基金持有人 →

常见问题

How long has Remedium Capital Partners, LLC held JBIO?

Remedium Capital Partners, LLC has disclosed JBIO holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Remedium Capital Partners, LLC's current position in JBIO?

As of Q3 2026, Remedium Capital Partners, LLC holds 1.81M shares of JBIO (JADE BIOSCIENCES INC), valued at $25.40M, representing 9.28% of its reported portfolio and ranking #4.

Has Remedium Capital Partners, LLC been buying or selling JBIO?

In the latest 13F filing (Q3 2026), Remedium Capital Partners, LLC increased its position in JBIO. The position peaked in Q2 2026 at 1.58M shares.

Which other funds hold JBIO?

Other major institutional holders of JBIO include Fairmount Funds Management LLC, RA CAPITAL MANAGEMENT, L.P., Venrock Adviser, LLC, among 97 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.